Thank you for activating your XIFAXAN Savings Card

Your XIFAXAN Savings Card is now activated and ready to use.

To use your card:
  • 1

    Simply present it at the pharmacy when you fill your XIFAXAN prescriptions.

  • 2

    The pharmacist will return your card; keep it in order to save on your copay each month for XIFAXAN.

  • 3

    For questions regarding your eligibility or benefits, see the Eligibility Criteria, Terms and Conditions contained below or call 1-866-XIFAXAN.

Eligibility Criteria, Terms and Conditions: This offer is only valid for commercially insured patients with coverage for XIFAXAN. Commercially insured patients without coverage for XIFAXAN or patients without commercial insurance are not eligible. Commercially-insured patients with coverage for XIFAXAN will receive savings to reduce their copay to as little as $0. Maximum benefits and number of uses apply. For information about the maximum benefits and number of uses please visit www.XIFAXAN.com and/or call the helpline 1-866-XIFAXAN (option 1). Patient is responsible for all additional costs and expenses after application of the maximum benefits. You must activate this coupon before using it by visiting XIFAXAN.com, calling 1-866-XIFAXAN, or texting PAYZERO to 69970. You will receive a link to activate your copay savings card via SMS and opt-in to refill reminders. Message and data rates may apply. Message frequency varies. Text HELP for help, STOP to opt out. The full terms can be viewed at https://XIFAXAN.copaysavingsprogram.com/sms-terms. The Privacy Policy can be viewed at https://www.bauschhealth.com/privacy. Salix Pharmaceuticals being a subsidiary of Bausch Health Companies, Inc. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. Offer excludes full cash-paying payments. By using this offer, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions described herein and will not seek reimbursement for any benefit received through this card. This offer is only good in the USA at participating retail pharmacies. This offer cannot be redeemed at other locations, including government-subsidized clinics or facilities. This offer is not valid where otherwise prohibited, taxed, or otherwise restricted. Patient is responsible for reporting receipt of co-pay assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. This offer cannot be combined with other offers. This card has no cash value. No other purchase is necessary. This offer is nontransferable. No substitutions are permitted. This card is not health insurance. You understand and agree to comply with the terms and conditions of this offer as set forth above. Salix Pharmaceuticals reserves the right to rescind, revoke, or amend this offer at any time without notice.

INDICATIONS

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.
  • If you take antibiotics, like XIFAXAN , there is a chance you could experience diarrhea caused by an overgrowth of bacteria ( C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
  • Talk to your healthcare provider before taking XIFAXAN if you have severe hepatic (liver) impairment, as this may cause increased effects of the medicine.
  • Tell your healthcare provider if you are taking drugs called P-glycoprotein and/or OATPs inhibitors (such as cyclosporine) because using these drugs with XIFAXAN may lead to an increase in the amount of XIFAXAN absorbed by your body.
  • In clinical studies, the most common side effects of XIFAXAN were:
    • HE: Peripheral edema (swelling, usually in the ankles or lower limbs), constipation, nausea (feeling sick to your stomach), fatigue (feeling tired), insomnia (trouble sleeping), ascites (a buildup of fluid in the abdomen), dizziness, urinary tract infection, anemia (low red blood cell levels), and itching
    • IBS-D: Nausea (feeling sick to your stomach) and an increase in liver enzymes
  • XIFAXAN may affect warfarin activity when taken together. Tell your healthcare provider if you are taking warfarin because the dose of warfarin may need to be adjusted to maintain proper blood-thinning effect.
  • If you are pregnant, planning to become pregnant, or nursing, talk to your healthcare provider before taking XIFAXAN because XIFAXAN may cause harm to an unborn baby or nursing infant.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:
Salix Product Information Call center
Phone: 1-800-321-4576
Fax: 1-510-595-8183

Please click here for full Prescribing Information.

The health information contained herein is provided for educational purposes only and is not intended to replace discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

SEE MORE

INDICATIONS

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria ( C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
{"crx-wl-channel":"web","crx-wl-survey-description":"Agreement Certification","crx-wl-survey-name":"Valeant- Xifaxan Survey v1.0.0","groupNumber":"AC68036002","client":"valeant","brand":"xifaxan","brandPath":"xifaxan","view":"print"}